{"id":244836,"date":"2026-10-02T21:03:27","date_gmt":"2026-10-03T02:03:27","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/10\/cell-preservation-technique-could-make-car-t-cell-therapy-more-accessible"},"modified":"2026-10-02T21:03:27","modified_gmt":"2026-10-03T02:03:27","slug":"cell-preservation-technique-could-make-car-t-cell-therapy-more-accessible","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/10\/cell-preservation-technique-could-make-car-t-cell-therapy-more-accessible","title":{"rendered":"Cell-preservation technique could make CAR-T cell therapy more accessible"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/cell-preservation-technique-could-make-car-t-cell-therapy-more-accessible2.jpg\"><\/a><\/p>\n<p>Immune cells that are engineered to attack cancer cells, known as CAR-T cells, are used to treat some types of blood cancer. However, only about 5 percent of hospitals in the United States have the ability to generate and deliver CAR-T cells to patients. For many patients, this means the cells need to be frozen and shipped long-distance.<\/p>\n<p>To help make this type of therapy accessible to more people, researchers at MIT have developed a new way to protect the cells from damage that can occur when they are frozen for storage and shipment. Their technique significantly reduces the use of a chemical preservative that is now used to protect the cells, which should make it easier for more hospitals to provide this treatment option to patients.<\/p>\n<p>Instead of treating the cells with a cryoprotective chemical that has to be removed before treatment, the researchers were able to preserve them using a nontoxic antifreeze sugar.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immune cells that are engineered to attack cancer cells, known as CAR-T cells, are used to treat some types of blood cancer. However, only about 5 percent of hospitals in the United States have the ability to generate and deliver CAR-T cells to patients. For many patients, this means the cells need to be frozen [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19],"tags":[],"class_list":["post-244836","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/244836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=244836"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/244836\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=244836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=244836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=244836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}